Table 4.
Weeks |
S1 |
S2 |
S3 |
|||
---|---|---|---|---|---|---|
Placebo, n = 4 | Palmvitee, n = 3 | Placebo, n = 17 | Palmvitee,n = 19 | Placebo, n = 7 | Palmvitee,n = 8 | |
|
Con A (SI) |
|||||
0 |
37.75 ± 15.73 |
24.50 ± 21.92 |
80.00 ± 48.12 |
55.26 ± 30.92 |
61.00 ± 15.41 |
53.75 ± 39.75 |
12 |
39.25 ± 15.09 |
55.00 ± 35.59 |
53.50 ± 35.02 |
59.32 ± 40.01 |
39.29 ± 20.77 |
61.63 ± 28.52* |
24 |
36.00 ± 32.65 |
22.00 ± 24.56 |
46.24 ± 28.03 |
49.26 ± 35.55 |
36.00 ± 20.94 |
35.75 ± 26.99 |
|
PHA (SI) |
|||||
0 |
58.00 ± 39.30 |
26.50 ± 6.36 |
73.17 ± 40.22 |
70.21 ± 44.99 |
67.29 ± 29.84 |
44.60 ± 28.53 |
12 |
60.50 ± 24.96 |
51.67 ± 30.62 |
69.44 ± 40.09 |
76.58 ± 35.20 |
60.29 ± 28.19 |
81.00 ± 38.53 |
24 | 59.25 ± 24.07 | 72.67 ± 69.82 | 74.71 ± 44.45 | 78.47 ± 68.50 | 62.29 ± 27.49 | 75.50 ± 32.96 |
Results are shown as means ± SD. * indicates significant difference as compared to nonsmokers.